Valeant expands dermatology portfolio with Solta acquisition

12/17/2013 | Reuters · Zacks

Valeant Pharmaceuticals will acquire medical-device-maker Solta before March 31, expanding its portfolio of aesthetic dermatology products. Solta products include the Thermage CPT radiofrequency skin tightening system, the Fraxel and Clear + Brilliant lasers and the Liposonix body-contouring device.

View Full Article in:

Reuters · Zacks

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ